Post-transfusion purpura
Post-transfusion purpura (PTP) is a rare but serious condition that can occur after a person receives a blood transfusion. PTP is characterized by a severe drop in the number of platelets in the blood, a condition known as thrombocytopenia, which occurs 5 to 12 days after the transfusion. This condition leads to an increased risk of bleeding and is more commonly observed in women, especially those who have been previously sensitized through pregnancy or prior transfusions.
Causes[edit | edit source]
PTP is caused by an immune response to platelet antigens, specifically the human platelet antigen-1a (HPA-1a). When an individual who lacks this antigen receives blood that contains it, their immune system may produce antibodies against the HPA-1a antigen. These antibodies can destroy the recipient's own platelets, leading to thrombocytopenia.
Symptoms[edit | edit source]
The primary symptom of PTP is the sudden onset of bleeding or purpura (purple bruises or spots on the skin) due to the severe decrease in platelet count. Other symptoms may include petechiae (small red or purple spots on the body), nosebleeds, bleeding gums, and in severe cases, internal bleeding.
Diagnosis[edit | edit source]
Diagnosis of PTP involves a combination of clinical assessment and laboratory tests. A history of recent blood transfusion, along with the symptoms of thrombocytopenia, can indicate PTP. Laboratory tests include complete blood count (CBC) to measure the platelet count and tests for antibodies against platelet antigens.
Treatment[edit | edit source]
Treatment of PTP focuses on increasing the platelet count and managing symptoms of bleeding. Intravenous immunoglobulin (IVIG) is the primary treatment and has been shown to be effective in increasing platelet counts. In some cases, steroids may also be used to suppress the immune response. Platelet transfusions are generally avoided as they can exacerbate the condition.
Prevention[edit | edit source]
Preventing PTP involves identifying at-risk individuals, such as those with known antibodies against platelet antigens, and using blood products that are matched or negative for the specific antigens. For individuals with a history of PTP, careful consideration and preparation are required before future transfusions.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD